Alexandros Fotopoulos - Nov 22, 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Technical Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
Nov 22, 2022
Transactions value $
-$4,948
Form type
4
Date filed
11/25/2022, 03:15 PM
Previous filing
Nov 14, 2022
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PASG Common Stock Options Exercise $0 +12.5K +109.03% $0.00 24K Nov 22, 2022 Direct F1, F2
transaction PASG Common Stock Sale -$4.95K -3.72K -15.52% $1.33 20.2K Nov 22, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Restricted Stock Units Options Exercise $0 -12.5K -25% $0.00 37.5K Nov 22, 2022 Common Stock 12.5K Direct F1, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The reported total includes 3,082 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).
F3 The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
F4 The reported transaction represents the settlement of restricted stock units which vested on June 15, 2022 but for which settlement was delayed due to an inadvertent administrative error.
F5 1/4 of the RSUs vested on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F6 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.